KCT0009256
尚未招募
未知
A prospective randomized controlled trial analyzing the clinical outcomes and patient satisfaction based on the implementation of the clinical pathway for Enhanced Recovery After Surgery program (ERAS CP) following oblique lumbar interbody fusion (OLIF)
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- Seoul National University Hospital
- 入组人数
- 38
- 状态
- 尚未招募
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •A. Patients who are able to ambulate independently for more than 30 minutes (see below for specific screening details):
- •i. Patients who, despite intermittent claudication, are able to reach a target distance of more than 30 minutes by taking breaks intermittently during ambulation are included.
- •ii. Patients who are able to reach a target distance of more than 30 minutes despite experiencing severe pain are also included.
- •B. Patients who visited the neurosurgery outpatient clinic for surgical treatment due to lumbar degenerative disease, requiring 1\-2 segmental fixation between lumbar 2 and sacral 1\.
- •C. Patients who voluntarily agree to participate in the research
排除标准
- •A. Patients who have previously undergone lumbar surgery.
- •B. Patients with muscle weakness of Manual Muscle Testing grade 3 or higher.
- •C. Patients with coexisting neuropsychiatric disorders, such as depression.
- •D. Patients with musculoskeletal diseases (inflammatory, myopathic, etc.) and infections other than lumbar degenerative disease.
- •E. Patients with concurrent malignant disease.
- •F. Patients who do not wish to participate in the research
结局指标
主要结局
未指定
相似试验
招募中
不适用
This is a randomized control trial in the setup of living donor liver transplant. Here we are assessing the role of synbiotic agents (pre and probiotics) in reducing infectious complications in the immediate post-operative period after liver transplant.Health Condition 1: null- Patients undergoing living donor liver transplant for CLDCTRI/2017/09/009869Amrita Institute of Medical Sciences Research Centre
已完成
不适用
Randomised controlled trial of bevacizumab in choroidal neovascularisation secondary to age-related macular degeneratioAge-related macular degenerationEye DiseasesISRCTN12980412Frimley Park Hospital NHS Trust (UK)100
已完成
4 期
A prospective randomised controlled trial assessing the efficacy of Pegatanib sodium (Macugen®) in the prevention of proliferative diabetic retinopathyISRCTN27864936Frimley Park Hospital NHS Foundation Trust (UK)90
尚未招募
不适用
A prospective randomized controlled trial evaluating the safety and efficacy of patient blood management program in patients with gynecologic cancerKCT0008092Asan Medical Center334
已完成
不适用
A prospective randomised controlled trial investigating three dimensional knee joint kinematics in total knee replacement – a comparison of cruciate retaining, posterior cruciate sacrificing and medially stabilised designs.OsteoarthritisMusculoskeletal - OsteoarthritisSurgery - Surgical techniquesACTRN12613001278729Professor Peter Choong90